Literature DB >> 21519817

Distinct mechanisms for rasburicase induced hemolytic anemia and methemoglobinemia in tumor lysis syndrome.

Rodrigo Lopes da Silva.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21519817     DOI: 10.1007/s11096-011-9511-4

Source DB:  PubMed          Journal:  Int J Clin Pharm


× No keyword cloud information.
  8 in total

1.  Hemolysis and methemoglobinemia secondary to rasburicase administration.

Authors:  Linda A Browning; James A Kruse
Journal:  Ann Pharmacother       Date:  2005-10-04       Impact factor: 3.154

2.  Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia.

Authors:  T Bauters; V Mondelaers; H Robays; H De Wilde; Y Benoit; B De Moerloose
Journal:  Int J Clin Pharm       Date:  2011-02-04

Review 3.  Role of oxidative stress in the pathogenesis of acute pancreatitis.

Authors:  J H Sweiry; G E Mann
Journal:  Scand J Gastroenterol Suppl       Date:  1996

4.  Free radicals generated by xanthine oxidase mediate pancreatitis-associated organ failure.

Authors:  E Folch; E Gelpí; J Roselló-Catafau; D Closa
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

Review 5.  [Rasburicase therapy may cause hydrogen peroxide shock].

Authors:  László Góth
Journal:  Orv Hetil       Date:  2008-08-24       Impact factor: 0.540

6.  Catalase deficiency may complicate urate oxidase (rasburicase) therapy.

Authors:  László Góth; N William Bigler
Journal:  Free Radic Res       Date:  2007-09

7.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

Authors:  B N Ames; R Cathcart; E Schwiers; P Hochstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

8.  Systemic inflammatory response syndrome and multiple organ dysfunction in patients with acute tumor lysis syndrome.

Authors:  Márcio Soares; Guilherme A Feres; Jorge I F Salluh
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.